top of page
HETERO ANALYTICAL LOGO
  • call logo
  • Whatsapp

Top 5 Mistakes in Pharma Stability Testing and How to Avoid Them

  • Writer: Ram Moondra DIGI
    Ram Moondra DIGI
  • Sep 8
  • 2 min read

Updated: Sep 28

Pharma Stability Testing : Stability testing is one of the most critical steps in pharmaceutical development. It ensures that drugs remain safe, effective, and compliant throughout their shelf life. However, even experienced labs can fall into common pitfalls that compromise results, delay approvals, and increase costs.


Top 5 Mistakes in Pharma Stability Testing and How to Avoid Them. Pharma Stability Testing.

Here are the top 5 mistakes in pharma stability testing — and how your lab can avoid them:


1. Inadequate Study Design

Many stability failures stem from poorly designed protocols that don’t meet ICH or regulatory expectations.

Avoid it by: Designing studies that reflect real-world storage, transportation, and use conditions, aligned with ICH guidelines.


2. Incorrect Storage Conditions

Drugs must be stored under tightly controlled conditions during stability studies. Small deviations can invalidate results.

Avoid it by: Using qualified stability chambers with continuous monitoring, alarms, and data integrity safeguards.


3. Neglecting Data Integrity

Missing, incomplete, or manipulated data can fail audits — even if results look acceptable.

Avoid it by: Following ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate, and more) for data handling.


4. Skipping Method Validation

Invalidated or non-stability-indicating methods risk overlooking degradation products.

Avoid it by: Validating all analytical methods according to ICH Q2(R1) to prove specificity, accuracy, and precision.


5. Poor Documentation & Change Control

Unclear or inconsistent documentation is one of the top audit failures in stability testing.

Avoid it by: Implementing strong SOPs, electronic records, and robust change-control systems.



Conclusion

Stability testing mistakes are costly but preventable. By ensuring robust study design, strict environmental controls, validated methods, and uncompromising data integrity, pharma companies can achieve faster approvals and stronger compliance.


At Hetero Analytical Solution LLP, our NABL-accredited lab provides end-to-end stability testing with validated methods, controlled conditions, and audit-ready documentation — helping you avoid risks and maintain trust.

 
 
 

Recent Posts

See All

Comments


bottom of page